SANGAMO THERAPEUTICS INC (SGMO) Institutional Ownership Changes & 13F Activity
SANGAMO THERAPEUTICS INC (SGMO). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Armistice Capital, Llc, Two Sigma Investments, Lp, Balyasny Asset Management L.P., Geode Capital Management, Llc, and Charles Schwab Investment Management Inc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Flow Traders U.S. Llc | Buy | +34 | +0.2% | 21,532 | $1.00K | Q2 2026 | Aug 14, 2026 |
| Simplex Trading, Llc | Buy | +76,500 | — | 76,500 | $4.13K | Q2 2026 | Aug 12, 2026 |
| Axiom Investment Management Llc | Buy | +22,875 | — | 22,875 | $1.24K | Q2 2026 | Jul 31, 2026 |
| Heritage Investment Group, Inc. | Buy | +10,000 | — | 10,000 | $539.00 | Q2 2026 | Jul 29, 2026 |
| Wells Fargo & Company/Mn | Sell | -38,330 | -100.0% | 0 | $0.00 | Q2 2026 | Jul 08, 2026 |
| Bank Of America Corp | Sell | -1,838,390 | -100.0% | 0 | $0.00 | Q2 2026 | May 18, 2026 |
| Armistice Capital, Llc | Sell | -40,400,067 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Two Sigma Investments, Lp | Sell | -6,270,441 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Balyasny Asset Management L.P. | Sell | -5,288,097 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Geode Capital Management, Llc | Sell | -4,570,862 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Charles Schwab Investment Management Inc | Sell | -2,352,360 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Jacobs Levy Equity Management, Inc | Sell | -2,050,384 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| State Street Corp | Sell | -1,694,783 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Susquehanna International Group, Llp | Sell | -1,687,463 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Luminus Management Llc | Sell | -1,681,089 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Ikarian Capital, Llc | Sell | -1,218,671 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Mak Capital One Llc | Sell | -561,538 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Morgan Stanley | Sell | -423,265 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Canada Pension Plan Investment Board | Sell | -397,100 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Goldman Sachs Group Inc | Sell | -377,287 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Mirae Asset Global Etfs Holdings Ltd. | Sell | -361,277 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Diametric Capital, Lp | Sell | -353,477 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Marshall Wace, Llp | Sell | -303,862 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Boothbay Fund Management, Llc | Sell | -277,311 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Captrust Financial Advisors | Sell | -268,755 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Fmr Llc | Sell | -244,139 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Cerity Partners Llc | Sell | -163,943 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Engineers Gate Manager Lp | Sell | -94,244 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Two Sigma Securities, Llc | Sell | -60,102 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Prelude Capital Management, Llc | Sell | -53,779 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
Frequently asked questions about SGMO activity
Which institutional owners are buying SGMO?
Institutional owners buying SGMO include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in SGMO activity?
"Buy" means an investor increased their reported position in SGMO compared to the prior reporting period. This reflects growing exposure to SANGAMO THERAPEUTICS INC (SGMO) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in SGMO increasing?
Institutional interest in SGMO can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related SGMO Institutional Insights
- SGMO Overview
- SGMO 13F Institutional Holders
- SGMO Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- SGMO Insider Trading & SEC Form 4 Activity
- SGMO Articles
- Top Institutional Investor Stock Rankings